Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page AWP72-AWP72, February 1, 2025. Background:Our system, comprised of 21 Northeast Ohio hospitals includes 3 Stroke Ready, 10 Primary and 1 Comprehensive Stroke Center (CSC). Clinical trials support the efficacy and safety of Tenecteplase for the treatment of acute ischemic stroke (AIS).

Strokes 40

Strokes Stroke Thrombolysis Nursing 40

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page A34-A34, February 1, 2024. A change in the stroke alert process (January 2023) focused on early notification of stroke alert, CT and telestroke. After changing the ED stroke process, there was a reduction in DTN of 29.26

Strokes 40

Strokes Stroke Thrombolysis Outcomes 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. IntroductionThe goal of this research project is to investigate the impacts and effects of the COVID‐19 pandemic on acute ischemic stroke treatment in North America. The most common way to treat these strokes is a mechanical thrombectomy.

COVID-19 40

COVID-19 Strokes Stroke Thrombolysis 40

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page ATP104-ATP104, February 1, 2024. Introduction:Accurate outcome prognostication in acute ischemic stroke (AIS) informs essential medical decision-making for clinicians, patients, and families. Cases with a modified Rankin scale (mRS) of 0-2 at 90 days (i.e.

Thrombolysis 40

Thrombolysis Strokes Stroke Outcomes 40

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page ATP278-ATP278, February 1, 2024. Subjects were divided into "intravenous thrombolysis group" and "non-intravenous thrombolysis group". Result:A total of 1971 patients (437 thrombolysis) were included. AIS with premorbid mRS ≤ 2 within 72 hours of onset was included.

Thrombolysis 40

Thrombolysis Thrombosis Strokes Stroke 40

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page A89-A89, February 1, 2024. Background and Aims:Treatment options for acute ischemic stroke (AIS) are uniquely dependent on the time of stroke onset. Intravenous thrombolysis must be administered within 4.5 Intravenous thrombolysis must be administered within 4.5 at <4.5

Strokes 40

Strokes Stroke Thrombolysis Technology 40

Circulation

OCTOBER 19, 2023

BACKGROUND:The thrombectomy-capable stroke center (TSC) is a recently introduced intermediate tier of accreditation for hospitals at which patients with acute ischemic stroke receive care. Participants were recruited from Get With The Guidelines–Stroke registry. 1.66]) and in TSCs compared with PSCs (OR, 1.45 [95% CI, 1.08–1.96]).

Strokes 40

Strokes Stroke Thrombolysis Certification 40

Stroke: Vascular and Interventional Neurology

AUGUST 21, 2023

Stroke: Vascular and Interventional Neurology, Volume 3, Issue 6 , November 1, 2023. middle cerebral artery occlusions), first‐pass effect (modified Thrombolysis in Cerebral Infarction score≥2B) was achieved in 90/166 (54.2%) successfully revascularized patients. female, 89.2% female, 89.2%

Strokes 40

Strokes Stroke Thrombolysis Outcomes 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page AHUP1-AHUP1, February 1, 2025. Introduction:Identification of modifiable drivers of the disparity between neighborhood socioeconomic status (nSES) and stroke outcomes remains elusive. We repeated the analyses stratified by stroke severity (NIHSS 5 or >5).Results:Among

Strokes 40

Strokes Stroke Outcomes Quality of Life 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page ADP53-ADP53, February 1, 2025. Introduction:Identification of modifiable drivers of the disparity between neighborhood socioeconomic status (nSES) and stroke outcomes remains elusive. We repeated the analyses stratified by stroke severity (NIHSS 5 or >5).Results:Among

Strokes 40

Strokes Stroke Outcomes Quality of Life 40

Stroke Journal

DECEMBER 21, 2023

Stroke, Volume 55, Issue 1 , Page 78-88, January 1, 2024. BACKGROUND:The association of COVID-19 with higher bleeding risk and worse outcomes in acute ischemic stroke (AIS) undergoing revascularization may be related to the presence of infection symptoms. 1.99]; aOR, 1.63 [95% CI, 1.14–2.32], 2.32], respectively).

COVID-19 40

COVID-19 Outcomes Strokes Stroke 40

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page AWP146-AWP146, February 1, 2024. Introduction:Intravenous thrombolytic therapy remains the cornerstone of management in acute ischemic stroke (AIS) patients.

ICU 40

ICU Critical Care Strokes Stroke 40

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page A24-A24, February 1, 2024. Introduction:Tenecteplase (TNK) has arisen as an alternative to alteplase (ALT) for emergent treatment of acute ischemic stroke. The exposure was treatment with TNK vs ALT. The primary endpoints were DTN and DIDO.

Strokes 40

Strokes Stroke Thrombolysis Hospital 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page ATP129-ATP129, February 1, 2025. In stroke, mechanical thrombectomy (MT) has revolutionized the field by providing an acute therapy with unprecedented reduction in morbidity and mortality. Its benefit depends heavily on the duration between stroke onset and cerebral reperfusion.

Thrombolysis 40

Thrombolysis Strokes Stroke Hospital 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. IntroductionThrombolysis with recombinant tissue plasminogen activator remains vital to acute ischemic stroke (AIS) therapy. The admission National Institutes of Health Stroke Scale scores (NIHSS) were similar. A p‐value of <0.05

Thrombolysis 40

Thrombolysis Pharmacology Strokes Stroke 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page AWP225-AWP225, February 1, 2025. Background:Intravenous thrombolysis (IVT) and mechanical thrombectomy (MT) are the standard of care for select stroke patients with acute large vessel occlusion (LVO). All patients consented to enrollment.Results:Forty-one patients were enrolled.

Hemorrhage 40

Hemorrhage Thrombolysis Strokes Stroke 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. IntroductionPatients with acute intracranial large vessel occlusions (LVO) in the drip‐and‐ship model are transferred from an outside hospital (OSH) to a comprehensive stroke center (CSC) after receiving thrombolysis.

Thrombolysis 40

Thrombolysis Hospital Strokes Stroke 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page ATMP32-ATMP32, February 1, 2025. Using data from GWTG-Stroke, researchers previously reported that, after minor ischemic stroke (NIHSS 0-3), the use of aspirin-clopidogrel for stroke prevention is highly variable despite guideline recommendations. from 2019 to 2023.

Strokes 40

Strokes Stroke Atrial Fibrillation Public Health 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page ATP301-ATP301, February 1, 2025. Background:Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) is the most common hereditary stroke disorder due to pathogenic variants in the NOTCH3 gene on chromosome 19. in 2018 to 2.8% vs 4.1%, p<0.001).

Hospital 40

Hospital Strokes Stroke Thrombolysis 40

Stroke: Vascular and Interventional Neurology

JANUARY 31, 2024

Stroke: Vascular and Interventional Neurology, Ahead of Print. BACKGROUNDPrior studies have shown benefit for endovascular therapy (EVT) in patients with large‐vessel occlusion and severe deficits, as captured by the National Institutes of Health Stroke Scale (NIHSS). The primary outcome was routine discharge (home or self‐care).

Inpatient 40

Inpatient Circulation Strokes Stroke 40

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page AWP199-AWP199, February 1, 2024. Background:The benefits of endovascular thrombectomy (EVT) for posterior cerebral artery (PCA) occlusion remain controversial, but intravenous thrombolysis (IVT) has proven benefit across nearly all ischemic stroke types.

Atrial Fibrillation 40

Atrial Fibrillation Thrombolysis Outcomes Embolism 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page AWP311-AWP311, February 1, 2025. Introduction:Cardiomyopathy (CM) can occur in patients hospitalized with acute ischemic stroke (AIS). Thrombolysis use was most frequent in patients with peripartum (18%), dilated (9.3%), drug-induced (8.8%), and ischemic CM (8.2%).

Hospital 40

Hospital Outcomes Strokes Stroke 40

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page AWP288-AWP288, February 1, 2024. Results:Between 2017 and 2022, 1,283,435 CVD cases were notified (SAH=4,7%; ICH= 8.8%; and ischemic stroke=86.5%). Results:Between 2017 and 2022, 1,283,435 CVD cases were notified (SAH=4,7%; ICH= 8.8%; and ischemic stroke=86.5%). were Male and 47.6%

Cerebrovascular Disease 40

Cerebrovascular Disease Thrombolysis Public Health Hemorrhage 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. The epidemiology and pathophysiology of coma in ischemic stroke has been underexplored. IntroductionComa is an unresponsive state of disordered consciousness characterized by impaired arousal and awareness.

Strokes 40

Strokes Stroke Thrombolysis Outcomes 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. Campbell, CA) have recently emerged as promising devices for treating acute ischemic stroke. All patients were treated by a single operator between January 2020 and March 2023. P‐values <0.05

Hemorrhage 40

Hemorrhage Thrombolysis Strokes Stroke 40